Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Prostatic Neoplasms 9Colorectal Neoplasms 5Breast Neoplasms 5Lung Neoplasms 4Hematopoietic and Lymphatic System Neoplasm 2Carcinoma, Non-Small-Cell Lung 2Advanced Malignant Solid Neoplasm 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Spondylitis, Ankylosing 1Sarcoma 1Pyloric Stenosis, Hypertrophic 1Psoriasis 1Overweight 1Ovarian Neoplasms 1Obesity-Related Malignant Neoplasm 1Obesity 1Neoplasm Metastasis 1Melanoma 1Malignant Solid Neoplasm 1Lymphoma 1Lupus Erythematosus, Systemic 1Inflammatory Bowel Diseases 1Hematopoietic and Lymphoid System Neoplasm 1Hematologic Neoplasms 1Glioblastoma 1Financial Stress 1Esophageal Neoplasms 1Crohn Disease 1

Interventions

cabozantinib 1anifrolumab 1Standard of Care 1Specimen Handling 1Procalcitonin 1Practice Guidelines as Topic 1Platinum Compounds 1Nivolumab 1Methods 1Ipilimumab 1Interviews as Topic 1Immune Checkpoint Inhibitors 1Educational Status 1Early Intervention, Educational 1CTLA-4 Antigen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Lupus Erythematosus, Systemic × Early Intervention, Educational × Clear all
NCT04751396 2026-05-20

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

M.D. Anderson Cancer Center

Recruiting
125 enrolled
Dermatologic

Arthritis, Rheumatoid, Autoimmune Diseases, Colitis, Ulcerative, Crohn Disease, Lupus Erythematosus, Systemic, Melanoma, Psoriasis, Spondylitis, Ankylosing, Inflammatory Bowel Diseases, Arthritis, Psoriatic, Arthritis, Reactive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡